Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
Status:
Withdrawn
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of enteral fish oil and UDCA on the time of cholestasis resolution
and other markers of parenteral nutrition-associated liver disease.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio